Global Study Lead

Global Study Lead - Oncology - Home Based

ICON is a global healthcare intelligence and clinical research organisation united by a mission to bring new medicines and treatments to patients faster.

As a values-driven organisation, integrity, collaboration, agility, and inclusion are at the heart of how we work and interact with each other, customers, patients and suppliers.

Role combines end-to-end design, execution, and reporting of clinical trials with leadership in project teams and across matrix teams. This position within GCD is accountable for planning and leading the delivery of oncology studies to time, quality, budget, company standards and scientific requirements as outlined in the clinical study proposal. This involves generating robust and accelerated delivery plans (with a focus on upper quartile performance) and delivering these to target or stretch thresholds.

The role may span oncology assets from early through to late phase of development and include delivery through one or more in-house, outsourced and alliance delivery models. This role is highly visible within Global Clinical Operations and in the Clinical Matrix Teams.

Key attributes include:

Demonstrated ability to input and influence studies/projects through operational expertise and demonstrated excellence in stakeholder management. This job requires competent strategic thinking, solution-finding, and agility as evidenced by flexibility, adaptability to change, curiosity, and ability to lead and drive change.

Essential behaviors include proven global leadership, continuous improvement and learning, effectiveness at building networks of partners and stakeholders, and ability to lead and inspire others. A track record of applying experience and judgement towards agile project decision-making, effective peer review, and shared learning is essential.

Key Responsibilities

• Accountable for the global study delivery strategy (e.g., country selection, diversity, patient engagement strategy, recruitment plan, etc.) and for overall study deliverables.
• Drive assessment, selection, engagement, management, and oversight of appropriate vendors.
• Ensure compliance with ICH/GCP guidelines, all applicable laws and regulations, and sponsor SOPs, for all products and services delivered for their designated studies.
• Make decisions which balance risk/benefit with clear understanding of impact on the study and project; takes action to mitigate risk where appropriate.
• Work with matrix partners, asset lead and/or manager to develop and manage study level budget within project allocation
• Preparation of materials for governance and / or financial review cycles and provide expert clinical operational input into protocol development.
• Lead and conduct investigator meetings and other study related meetings and participate in governance meetings as necessary.
• Identify and communicate resource gaps for assigned studies.
• Lead risk management and quality efforts to ensure study compliance and continual inspection readiness.
• Lead / contribute to ways of working and process improvement initiatives. Encourage others within matrix and line teams to seek alternative perspectives and develop solutions.
• Partner with Data Management and Clinical Sciences to develop the data cleaning strategy for the study and collaborate with Oncology aligned staff in global functions to deliver the Clinical Study Report.
• Work with the Oncology patient councils to develop patient centric documents and address patient burden.

What you need to have:

• Bachelor's degree in life sciences or related discipline.
• Extensive clinical development experience that is equivalent to 6 years as a global study leader with proven experience in driving operational study delivery to time, cost, and quality within the pharmaceutical industry or CRO environment.
• Proven operational experience leading global oncology clinical trials and knowledge of essential global regulatory guidelines and ICH/GCP.
• Proactively identify and resolve issues to ensure timely study delivery to quality, timelines, and budget.
• Proven leadership skills, influencing and negotiation skills.
• Demonstrated experience leading in the matrix environment to deliver projects, develop clinical plans and manage change.

Preferred Qualifications

• Oncology phase III global registrational study leadership experience.
• Proven clinical development experience across all phases of development (I-IV).
• Experience of innovative trial design (platform, basket, umbrella, adaptive designs) and decentralized trials (DCT) initiatives.
• Highly developed communication skills appropriate to the target audience, promoting effective decision-making where necessary and ability to manage conflict.
• Proven expertise in the proactive identification of issues which may impact clinical programs coupled with the ability to contribute to solutions affecting cross-functional matrix teams.
• Creative thinker able to modernize approach to clinical delivery, leverage externally.

Employment with ICON is contingent upon having the legal right to work in the country where the role is based.

Rewards & Benefits

ICON offers a competitive and comprehensive total rewards package designed to support your health, wellbeing, and career development.

Benefits may include:

• Competitive base salary and performance related incentives
• Health and wellbeing programmes including medical, dental, and vision coverage where applicable
• Retirement and pension plans
• Life assurance and disability coverage
• Employee assistance programmes and wellbeing resources
• Learning and development opportunities through structured training and career pathways

Benefits may vary depending on role and location.

Visit our careers site to read more about the benefits ICON offers.

Inclusion and Accessibility

ICON is an equal opportunity employer. We are committed to building an inclusive and accessible workplace where everyone feels valued and supported.

If you require reasonable accommodations during the recruitment process, please let us know or submit a request here.